ProKidney Corp. (PROK)
1.75
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
1.755
0.00 (0.00%)
Pre-Market: 09:07
ProKidney Shareholders Equity (Quarterly) : -1.024B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 13.80M |
| Karyopharm Therapeutics, Inc. | -265.65M |
| Rocket Pharmaceuticals, Inc. | 238.04M |
| ARS Pharmaceuticals, Inc. | 61.31M |
| Korro Bio, Inc. | 119.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 292.78M |
| Total Liabilities (Quarterly) | 29.68M |
| Debt to Equity Ratio | -0.0037 |
| Current Ratio | 9.059 |
| Net Debt Paydown Yield | -0.04% |